Data from the Phase III FRONTIER3 trial found that 98% of caregivers prefer Mim8 for hemophilia A over other treatments.
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.
These super high-flying US stocks have soared 222%, 122%, and 150%, respectively, in 2025. Let's take a look why.
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing important information going beyond just progesterone-only or combined.
Besides the Gardasil litigation, Wisner Baum is active in lawsuits concerning Pfizer's injectable birth control drug Depo-Provera, Novo Nordisk's Ozempic, Indivior's pain drug Suboxone and other ...
Rep. Chip Roy (R-TX) issued a diagnosis for America’s broken health care system, and the congressman says the problem isn’t ...
“If we want to control our budgets and health care spending ... The drugmaker behind weight loss drugs Wegovy, Saxenda, and Ozempic, Novo Nordisk, has spent $25.8 million over the past decade ...
Robert F. Kennedy Jr. faces high-stakes Senate hearings as he seeks confirmation for Health Secretary. This live blog is now ...
A US federal judge has temporarily halted Donald Trump’s executive order to end citizenship at birth. Earlier this ... they exploded in popularity. Novo Nordisk, which makes Ozempic, became ...
RFK Jr.'s bid for top health job faces Senate committee hurdle on Tuesday Novo Nordisk's blockbuster ... insurance access to over-the-counter birth control pills and other contraceptives at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results